ZANTE GREG Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
13
Insider Sells Sum
$23.32M

Insider Activity of ZANTE GREG

According to the SEC Form 4 filings, ZANTE GREG, being in a position of

  1. Chief Financial Officer at Viking Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 78878 shares for $2.61M,
    over all time since 2023-03-30, has bought 0 shares, and sold 636496 shares for $26.05M.

Biography of ZANTE GREG

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $2,607,1112100

Comparison of Insiders on Amount of Buys and Sells

2026-07-29SaleViking Therapeutics, Inc.
VKTX
Chief Financial Officer
21,217
0.0183%
$33.47$710,141-3.84%
2026-01-05SaleViking Therapeutics, Inc.
VKTX
Chief Financial Officer
57,661
0.0522%
$32.90$1.9M+0.78%
2025-10-28SaleViking Therapeutics, Inc.
VKTX
Chief Financial Officer
6,185
0.0057%
$35.00$216,481-4.55%
2025-07-03SaleViking Therapeutics, Inc.
VKTX
Chief Financial Officer
4,266
0.0037%
$27.76$118,428+15.73%
2025-01-06SaleViking Therapeutics, Inc.
VKTX
Chief Financial Officer
50,309
0.0453%
$42.75$2.15M-29.98%
2024-10-28SaleViking Therapeutics, Inc.
VKTX
Chief Financial Officer
131,687
0.1468%
$76.61$10.09M-60.04%
2024-07-30SaleViking Therapeutics, Inc.
VKTX
Chief Financial Officer
16,136
0.0147%
$57.15$922,212-40.73%
2024-05-03SaleViking Therapeutics, Inc.
VKTX
Chief Financial Officer
66,756
0.0587%
$74.69$4.99M-32.82%
2024-01-04SaleViking Therapeutics, Inc.
VKTX
Chief Financial Officer
15,000
0.0144%
$17.90$268,500+225.03%
2023-04-17SaleViking Therapeutics, Inc.
VKTX
Chief Financial Officer
7,500
0.0098%
$20.00$150,000-4.46%
2023-04-12SaleViking Therapeutics, Inc.
VKTX
Chief Financial Officer
41,544
0.0538%
$18.00$747,792+4.99%
2023-04-11SaleViking Therapeutics, Inc.
VKTX
Chief Financial Officer
56,295
0.0731%
$18.00$1.01M+5.12%
2023-04-03SaleViking Therapeutics, Inc.
VKTX
Chief Financial Officer
30,911
0.0404%
$18.00$556,398+3.24%
2023-03-30SaleViking Therapeutics, Inc.
VKTX
Chief Financial Officer
131,029
0.1641%
$17.00$2.23M+3.12%
Total: 14
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.